BiochemProbe — Life Science Research Reagents

Leucettine L41 free base

Leucettine L41 is a potent inhibitor of dual-specificity tyrosine phosphorylation-regulated kinases.

For research use only. Not for human or veterinary use.

Purity >98% Stock Inquire

Leucettine L41 structure

CAS No.: 1112978-84-3

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
100 mg USD 610.00 BP-02182-100mg In stock Get quote
250 mg USD 1,240.00 BP-02182-250mg In stock Get quote
500 mg USD 1,970.00 BP-02182-500mg In stock Get quote
1 g USD 3,150.00 BP-02182-1g In stock Get quote

Need another size or custom synthesis? Request a quote.

Description

Leucettine L41 is a potent inhibitor of dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) and CDC-like kinases (CLKs). Leucettine L41 can also inhibit GSK-3 singnaling. Leucettine L41 can inhibit cell apoptosis and ROS production. Leucettine L41 can promote β-cell cell cycle progression, cell proliferation and increase insulin secretion. Leucettine L41 can be used for the researches of neurological disease and metabolic disease, such as Alzheimer’s disease (AD) and diabetes .

Biological activity

In Vitro Leucettine L41 (0.01-100 μM) increases viability and proliferation in MIN6 cells. Leucettine L41 (5 μM, 24 h) increases cells in G2/M phase in MIN6 cells. Leucettine L41 (5 μM, 24 h) increases insulin and C-peptide production in MIN6 cells. Leucettine L41 improves insulin secretion in isolated mouse islets. In Vivo Leucettine L41 (0.4-4 μg, i.c.v.) prevents memory deficits and neurotoxicity in Aβ25-35-treated mice.

Identifiers

SMILES
O=C1NC(NC2=CC=CC=C2)=N/C1=C\C3=CC=C(OCO4)C4=C3
InChIKey
PGPHHJBZEGSUNE-JYRVWZFOSA-N

Specifications

MW (average)
307.3034
Formula
C17H13N3O3
CAS No.
1112978-84-3
Physical state
Solid
Color
Light yellow to yellow
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 3 years; 4℃ 2 years; In solvent -20℃ 1 month;

Solubility

soluble in DMSO

References

[1]. Naert G, et al. Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice. Eur Neuropsychopharmacol. 2015 Nov;25(11):2170-82.
[2]. Pucelik B, et al. DYRK1A inhibitors leucettines and TGF-β inhibitor additively stimulate insulin production in beta cells, organoids, and isolated mouse islets. PLoS One. 2023 May 17;18(5):e0285208.

Same target

Search DYRK

Same research area

Search Neurological Disease